In lung cancer, treatment with oridonin (0–10 μM) for 24 h suppressed cell migration, invasion, and adhesion of H1975 human non-small cell lung cancer (NSCLC) cell line through suppression of phosphorylation of EGFR and its downstream signaling pathway via ERK [60]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.